Robert A. Jabulowsky

2.9k total citations
10 papers, 189 citations indexed

About

Robert A. Jabulowsky is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Robert A. Jabulowsky has authored 10 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Robert A. Jabulowsky's work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and vaccines and immunoinformatics approaches (2 papers). Robert A. Jabulowsky is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and vaccines and immunoinformatics approaches (2 papers). Robert A. Jabulowsky collaborates with scholars based in Germany, United States and Israel. Robert A. Jabulowsky's co-authors include Pranav Oberoi, Winfried S. Wels, Hayat Bähr-Mahmud, Benjamin Dälken, Jeffrey S. Han, Roswitha Löwer, André Berger, Egbert Flory, Carsten Münk and Ananda Ayyappan Jaguva Vasudevan and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Robert A. Jabulowsky

10 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Jabulowsky Germany 7 114 62 51 45 38 10 189
N. Hess Germany 8 155 1.4× 81 1.3× 39 0.8× 79 1.8× 53 1.4× 13 285
Taiyuan Li China 12 190 1.7× 32 0.5× 46 0.9× 26 0.6× 32 0.8× 31 283
Manuel Rhiel Germany 9 212 1.9× 36 0.6× 64 1.3× 58 1.3× 15 0.4× 13 303
Angela Hückelhoven Germany 8 102 0.9× 94 1.5× 150 2.9× 51 1.1× 80 2.1× 12 307
Kenta Sasaki Japan 9 119 1.0× 52 0.8× 84 1.6× 28 0.6× 14 0.4× 25 276
Alessio D. Nahmad Israel 4 165 1.4× 47 0.8× 105 2.1× 86 1.9× 9 0.2× 5 231
Jayne M. Christen United States 6 89 0.8× 95 1.5× 29 0.6× 18 0.4× 30 0.8× 8 186
Elham Fakhr Germany 7 212 1.9× 79 1.3× 117 2.3× 53 1.2× 12 0.3× 9 329
Elena Montauti United States 8 199 1.7× 77 1.2× 59 1.2× 57 1.3× 15 0.4× 9 361

Countries citing papers authored by Robert A. Jabulowsky

Since Specialization
Citations

This map shows the geographic impact of Robert A. Jabulowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Jabulowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Jabulowsky more than expected).

Fields of papers citing papers by Robert A. Jabulowsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Jabulowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Jabulowsky. The network helps show where Robert A. Jabulowsky may publish in the future.

Co-authorship network of co-authors of Robert A. Jabulowsky

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Jabulowsky. A scholar is included among the top collaborators of Robert A. Jabulowsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Jabulowsky. Robert A. Jabulowsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Loquai, Carmen, Jessica C. Hassel, Petra Oehm, et al.. (2020). A shared tumor-antigen RNA-lipoplex vaccine with/without anti-PD1 in patients with checkpoint-inhibition experienced melanoma.. Journal of Clinical Oncology. 38(15_suppl). 3136–3136. 17 indexed citations
2.
Jabulowsky, Robert A., Carmen Loquai, Evelyna Derhovanessian, et al.. (2018). A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. Annals of Oncology. 29. viii439–viii439. 6 indexed citations
3.
Heesen, Ludwig, Robert A. Jabulowsky, Carmen Loquai, et al.. (2017). A first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for potent melanoma immunotherapy. Annals of Oncology. 28. xi14–xi15. 9 indexed citations
4.
Erbar, Stephanie, Robert A. Jabulowsky, Tim Beißert, et al.. (2017). Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles. Scientific Reports. 7(1). 16892–16892. 24 indexed citations
5.
Kloke, Björn‐Philipp, et al.. (2014). Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6–8, 2014. Cancer Immunology Immunotherapy. 64(7). 923–930. 4 indexed citations
6.
Jung‐Klawitter, Sabine, Ulrike Held, André Berger, et al.. (2013). Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity. Nucleic Acids Research. 42(1). 396–416. 68 indexed citations
7.
Oberoi, Pranav, Robert A. Jabulowsky, Hayat Bähr-Mahmud, & Winfried S. Wels. (2013). EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor Cells. PLoS ONE. 8(4). e61267–e61267. 27 indexed citations
8.
Oberoi, Pranav, Robert A. Jabulowsky, & Winfried S. Wels. (2013). Selective Induction of Cancer Cell Death by Targeted Granzyme B. SHILAP Revista de lepidopterología. 2(1). 130–151. 6 indexed citations
9.
Jabulowsky, Robert A., Pranav Oberoi, Hayat Bähr-Mahmud, Benjamin Dälken, & Winfried S. Wels. (2012). Surface Charge-Modification Prevents Sequestration and Enhances Tumor-Cell Specificity of a Recombinant Granzyme B–TGFα Fusion Protein. Bioconjugate Chemistry. 23(8). 1567–1576. 13 indexed citations
10.
Dälken, Benjamin, Robert A. Jabulowsky, Pranav Oberoi, Itai Benhar, & Winfried S. Wels. (2010). Maltose-Binding Protein Enhances Secretion of Recombinant Human Granzyme B Accompanied by In Vivo Processing of a Precursor MBP Fusion Protein. PLoS ONE. 5(12). e14404–e14404. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Hess Breakdown of academic impact, for papers by Taiyuan Li Breakdown of academic impact, for papers by Manuel Rhiel Breakdown of academic impact, for papers by Angela Hückelhoven Breakdown of academic impact, for papers by Kenta Sasaki Breakdown of academic impact, for papers by Alessio D. Nahmad Breakdown of academic impact, for papers by Jayne M. Christen Breakdown of academic impact, for papers by Elham Fakhr Breakdown of academic impact, for papers by Elena Montauti
Rankless by CCL
2026